Lactobacillus plantarum P 17630 + Lactobacillus paracasei I 1688 + Lactobacillus salivarius I 1794 with vitamin B1 (0,6 mg) + vitamin B2 (0,5 mg). Ratio: 200:4.9:0.1 Intestinal dysbiosis. Leaky bowel syndrome. Health and well-being of the mucous membranes. Intestinal microflora imbalance: diarrhea, constipation, bloating, abdominal pain, intestinal gas production. Immunomodulating action, it acts on anti-inflammatory …
Constipation • Intestinal transit
Lactobacillus paracasei I 1688 + Lactobacillus salivarius I 1794 with vitamin B1 (0,6 mg) + vitamin B2 (0,5 mg). Ratio: 12:1 Restoration of the physiological intestinal balance. Pediatric gastroenteritis. Immunomodulatory activity in allergic patients (for asthma and allergic rhinitis). Induces a significant reduction of LDL cholesterol, as well as a significant improvement of the LDL …
Constipation • Intestinal transit • Reduction of gastrointestinal discomfort • Leaky gut • Strengthening of natural defences and natural immunity • Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
L. rhamnosus Rosell®-11 + L. helveticus Rosell®-52 Diarrhea, Antibiotic-Associated Diarrhea, H. pylori eradication therapy, Atopic Dermatitis Lactose intolerance in children and adults 2B CFU Atopic Dermatitis in children 2B CFU Antibiotic-associated diarrhea in children and in adults from 1B to 12B depending on age Adjunct to physician-supervised therapy in children and adults with Helicobacter pylori …
Constipation • Intestinal transit • Anti-inflammatory • Reduction of gastro-intestinal discomfort • Inhibition of pathogenic E. coli • Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production • Prospective use in the treatment of obesity • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction …
Probi Digestis® is based on the probiotic strain Lactiplantibacillus plantarum 299v (LP299V®). LP299V® has been documented within several areas, all related to health benefits in the gut. It is described in more than 200 scientific publications and has been subject to more than 70 clinical studies. Clinical results have been shown within areas reaching from …
Probi FerroSorb® is based on the probiotic strain Lactiplantibacillus plantarum 299v (LP299V®) and a balanced amount of iron. Probi FerroSorb has in several different studies been shown to significantly increase iron absorption, both taken as a food supplement and in food formats. Long-term effects on iron status have been studied in healthy, non-anemic female athletes …
HappyBelly is a probiotic complex by SynBalance, specifically designed to support children’s gastrointestinal health.HappyBelly has been clinically tested in a randomized double blind placebo controlled clinical trial. 100 IBS-C subjects were randomly divided in two groups 50 supplemented with a daily dose of 4B/ day for 60 days + 30 days of follow-up and 50 …
Reduction of gastro-intestinal discomfort related to IBS • Rebalance of intestinal microbiota • Non-transmissible rifamycins resistance • Production of Exopolysaccharides • Hepatic encephalopathy
Constipation • Intestinal transit • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
SmilinGut is a probiotic complex by SynBalance, specifically designed to support gastrointestinal health.SmilinGut has been clinically tested in a randomized double blind placebo controlled clinical trial. 100 IBS-C subjects were randomly divided in two group 50 supplemented with a daily dose of 6B/ day for 60 days + 30 days of follow-up and 50 supplemented …
Rebalance of intestinal microbiota • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Rebalance of intestinal microbiota
Gaseous colic • Inhibition of E. coli, including toxinogenic O157:H7 • Inhibition of Klebsiella pneumoniae and of different coliforms isolated from colicky infants • Inhibition of pathogens E. coli, Klebsiella and gas-producing coliforms
Inhibition of pathogenic Candida species • Restoration of a physiological gut barrier • Inhibition of Candida growth • Strain from brushing of the gut mucosa
Inhibition of pathogenic Candida species • Vaginal health • Inhibition of Candida strains • Counteraction of vulvovaginal candidiasis (VVC)
Rebalance of intestinal microbiota
Inhibition of E. coli
Constipation • Intestinal transit • Leaky gut • Inhibition of E. coli• Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Cystitis • Inhibition of E. coli
Anti-pathogen activity
Production of reuterin and vitamin B12 • Anti-pathogen activity and immunostimulation (induction of IFN-gamma) • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Diarrhea • Rotaviral diarrhea • Gastroenteritis Also available as Active Pharmaceutical Ingredient (API) Autism and ADH prevention • Oral health • Caries prevention • Inhibition of Streptococcus mutans
Diarrhea • Inhibition of E. coli, including enterohemorrhagic O157:H7 • Cystitis • Inhibition of E. coli
Inhibition of E. coli • Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Inhibition of Enterococcus faecalis, Enterococcus faecium and Neisseria gonorrhoeae • Vaginal health • Prevention of urogenital infections • Inhibition of Candida
Rebalance of intestinal microbiota
Daily dosage in clinical study: 1 billion CFU
Restoration of the physiological intestinal balance. Pediatric gastroenteritis. Immunomodulatory activity in allergic patients (for asthma and allergic rhinitis). Induces a significant reduction of LDL cholesterol, as well as a significant improvement of the LDL / HDL ratio. Reduces the release of type 2 cytokines, induces an improvement in the th1 / th2 ratio. Deposited at …
Restoration of the physiological intestinal balance. Pediatric gastroenteritis. Immunomodulatory activity in allergic patients (for asthma and allergic rhinitis). Induces a significant reduction of LDL cholesterol, as well as a significant improvement of the LDL / HDL ratio. Reduces the release of type 2 cytokines, induces an improvement in the th1 / th2 ratio. Deposited at …
Allergy. Intestinal dysmicrobisms caused by antibiotic therapies. Diarrheal and dyspeptic syndromes due to altered bacterial flora (diarrhea, non-specific enteritis, colitis). Traveler’s diarrhea prevention. They are deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 18805. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural …
Allergy. Intestinal dysmicrobisms caused by antibiotic therapies. Diarrheal and dyspeptic syndromes due to altered bacterial flora (diarrhea, non-specific enteritis, colitis). Traveler’s diarrhea prevention. Deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 18806. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural origin (OMG …
Allergy. Intestinal dysmicrobisms caused by antibiotic therapies. Diarrheal and dyspeptic syndromes due to altered bacterial flora (diarrhea, non-specific enteritis, colitis). Traveler’s diarrhea prevention. Deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 18807. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural origin (OMG …
Balance of the intestinal flora. It helps the normal function of the neuron system and psychological function. It also contributes to the normal cognitive function. L. plantarum LM2 and L. brevis Y1 produce, respectively, Acetylcholine (Ach) and Gamma-aminobutyric acid (GABA), inhibitory neurotransmitter. It has an immunomodulating action, it helps reinforce the body’s natural defenses and …
The probiotic strain Bifidobacterium lactis Lafti® B94 has been specifically documented in the area of gut health. It benefits from a strong body of clinical evidence, supported by in vitro and in vivo documentation of its modes of action. A converging body of clinical evidence: digestive comfort Gut transit in all population groups (infants from birth, children, adolescents, adults): Bifidobacterium animalis …
L. plantarum WJL is a second precision probiotic developed by TargEDys in collaboration with the Functional Genomics Institute of Lyon, selected by its ability to optimize the amino acid absorption, by a stimulation of the somatotroic axis. The potenital of this strain is large: from children growth, elderly bones and muscle mass, sport nutrition to …
Lactobacillus reuteri LR 92 LR92 is the first and only probiotic strain that has clinically demonstrated to significantly reduce the incidence of infantile colic in the newborn child, when given, to the mothers, in the last months of pregnancy. By improving the health of the infant, LR 92 helps mothers to live more serenely during …
Lactiplantibacillus plantarum 299v (LP299V®) is the most clinically documented L. plantarum strain in the world. LP299V® has been documented within several areas, all related to health benefits in the gut. It is described in more than 200 scientific publications and has been subject to more than 70 clinical studies. Clinical results have been shown within …
Lactiplantibacillus plantarum 299v (LP299V®) (DSM 9843) Read More »
Several studies have shown that Lactiplantibacillus plantarum 6595 (Probi® Plantarum 6595) survives the passage through the GI tract, and attaches to the intestinal cells through a specific mannose-dependent binding mechanism. The bacteria can thereby exert its effects on the intestinal wall, and immune system. Lactiplantibacillus plantarum 6595 (Probi® Plantarum 6595) has also been shown to …
Lactiplantibacillus plantarum 6595 (Probi® Plantarum 6595) Read More »
MicrobiomeHUB is a space that brings together the companies of the microbiome industry
Brought to you by Clorofilla Scientific Publishing
Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963
© ALL RIGHTS RESERVED
